Vomaris’s JumpStart® Product Recognized with Sports Medicine New Technology Award
Tempe, Arizona – July 12, 2016
Orthopedics This Week’s 2016 Sports Medicine Technology Award goes to Advanced Microcurrent Technology®; seen as the New Generation in Wound Care, with Non-pharmacologic Solution to Antimicrobial Efficacy
Vomaris Innovations, Inc., announced today that the company’s Advanced Microcurrent Technology (AMT) platform has earned RRY Publications, LLC and Orthopedics This Week’s Sports Medicine Technology Award for 2016. This annual award recognizes excellence in sports medicine innovation and celebrates the physicians, scientists and engineers who are creating the next generation of innovative products, which will significantly improve care for athletes of all performance levels. The Vomaris team received its award at the 2016 American Orthopaedic Society for Sports Medicine annual meeting in Colorado Springs on July 8, 2016.
The Sports Medicine Technology Award is sponsored by Orthopedics This Week, the leading publication in orthopedics with more than 180,000 monthly readers. Following a categorization and analysis process, winning technologies were selected by a respected panel of leading sports medicine physicians, including James Andrews MD, Brian Cole MD, Thomas Vangsness MD, David Petron MD and John Dorris MD.
Utilizing electricity to mimic the body’s own physiologic electric currents which are essential for skin repair and wound healing, Vomaris’s core platform – Advanced Microcurrent Technology – employs embedded moisture-activated microcell batteries that generate microcurrents. It is a new generation solution for wound and incisional care with demonstrated broad-spectrum antimicrobial efficacy – including antibiotic-resistant1 and biofilm-forming2-3 bacteria – and the ability to support the body’s natural healing process.4 This is increasingly important as heightened concern about ‘super bugs’ (i.e. drug-resistant microbes) and infections drives the need for a non-pharmacologic approach to antimicrobial efficacy.
Vomaris’s AMT is distributed in the US Sports Medicine and Orthopedic Surgery Markets under the name JumpStart, exclusively through Arthrex, Inc., and plans are underway for geographic expansion.
“There is a growing concern among orthopedic surgeons and sports team trainers about surgical sites infections and locker room or playing field-acquired infections. Both can have a serious impact on the patient’s rehabilitation at a minimum, and in some cases, can be catastrophic. At Arthrex, we are proud to provide our customers with a scientifically and clinically validated, non-pharmacologic solution to reduce risk of infection while supporting wound healing,” commented David Shepard, Senior Director, Orthobiologics at Arthrex. “Recognition by Orthopedics This Week and their prestigious review panel affirms our efforts.”
Orthopedics This Week founder, Robin Young stated: “JumpStart antimicrobial wound dressing is a truly innovative technology and earned the panel’s top scores. Patients, physicians, hospitals, and reimbursers rely on the inspiration and perspiration of engineers and scientists to improve outcomes and control costs. We are proud to present this award to the Vomaris team and to publically recognize their exceptional talent and significant contribution to patient care.”
- Kim H, et al. Antibacterial Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Pathogens. The Open Microbiology Journal 2014; 8:15-21.
- Banerjee J, et al. (2015) Silver-zinc Redox-coupled Electroceutical Wound Dressing Disrupts Bacterial Biofilm. PLoS ONE 10(3): e0119531. doi:10.1371/journal.pone.0119531.
- Kim H, Izadjoo MJ. Antibiofilm Efficacy Evaluation of a Bioelectric Dressing in Mono- and Multi-species Biofilms. J Wound Care 2015; 24 Suppl 2:S10-4.
- Zhao M. Electrical Fields in Wound Healing – An Overriding Signal That Directs Cell Migration. Semin Cell Dev Biol; 20(6):674-82.